CHRETO ApS: Financial statements 2013
CVR: 33382170
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
CHRETO ApS (CVR 33382170) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 13,054 and a net result of DKK 13,142. Equity in the 2013 report amounted to DKK 162,432. The solvency ratio was 9.5%.
- Gross Profit
- DKK 13,054
- Profit/Loss
- DKK 13,142
- Equity
- DKK 162,432
- Total Assets
- DKK 1,701,978
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of May 7, 2013, Svend Erik Licht has joined the board of directors of CHRETO ApS.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of CHRETO ApS.
About CHRETO ApS
CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The board consists of Johan Caspar Foghsgaard (chair), Anders Wikström, Frank Bech Nygaard and Kim Bjørnstrup. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity in the 2025 report amounted to DKK 49,010,862.